Biomarkers and Precision Medicine Community (BPMC)

Please join for the second Open Scientific Discussion (OSD) in the Biomarker Strategy series hosted by the AAPS Biomarkers and Precision Medicine (BPM) and Gene and Cell Therapy Products (GCTP) Communities on January 22^nd, 12 – 1 pm EST on the following topic:

Context of Use: Bridging Biomarker Strategy with Analytical Excellence (Part 2)

• What transforms a good biomarker strategy into a great one?
• How good does an assay need to be (where do we set the bar)?
• How does one select the appropriate analytical platform for biomarker assessments?
• Case studies of different context of use scenarios will be presented

Discussion Leaders:

• Yan Ni (Passage Bio)
• Karen Quadrini (Prothena Biosciences)
• Joel Mathews (Ionis Pharmaceuticals)

Organized by:  Karen Quadrini (Prothena Biosciences), Carmen Fernández-Metzler (PharmaCadence), Ayuko Ota-Setlik (Regeneron)